DMD and Duchenne muscular dystrophy: Seminal work from the Olson, Gersbach, and Wagers laboratories independently demonstrated CRISPR/Cas can be used to recover a partially functioning dystrophin via a NHEJ mechanism in a mouse model of DMD (Long et al., 2016; Nelson et al., 2016; Tabebordbar et al., 2016).